Emerald Mutual Fund Advisers Trust’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-419,462	Closed	-$14M	–	252
2024 Q3	$14M	Buy	419,462 +235,885	+128%	+$8.12M	0.73%	56
2024 Q2	$4.96M	Buy	+183,577	New	+$3.62M	0.26%	102

Emerald Mutual Fund Advisers Trust's LBPH Position: Q4 2024 in Review

Emerald Mutual Fund Advisers Trust sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 419,462 shares — an estimated $14M sold.

Emerald Mutual Fund Advisers Trust first reported a position in LBPH in Q2 2024 and held it in 2 quarters. The position peaked at $14M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Emerald Mutual Fund Advisers Trust reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 419,462 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $14M.
Emerald Mutual Fund Advisers Trust first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
Emerald Mutual Fund Advisers Trust's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $14M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2024, filed 14 Feb 2025.